Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/20/2012US20120322749 Tableted compositions containing atazanavir
12/20/2012US20120322748 Novel peptides that enhance tight junction permeability
12/20/2012US20120322747 Beta-turn peptidomimetic cyclic compounds for treating dry eye
12/20/2012US20120322746 Methods, compositions, and kits for the treatment of ophthalmic disorders
12/20/2012US20120322745 Optimized method for obtaining ace activity inhibitory peptides from whey, ace inhibitory peptides and food comprising them
12/20/2012US20120322744 Poly-pegylated protease inhibitors
12/20/2012US20120322743 Compositions and Methods for Diagnosing and Treating Melanoma
12/20/2012US20120322742 Therapeutics to inhibit mll-menin interaction for treating leukemia
12/20/2012US20120322741 Psma binding ligand-linker conjugates and methods for using
12/20/2012US20120322740 Mu opioid receptor agonist analogs of the endomorphins
12/20/2012US20120322739 Albumin Variants
12/20/2012US20120322738 Conjugated fviii variants
12/20/2012US20120322737 Modified recombinant factor viii and von willebrand factor and methods of use
12/20/2012US20120322736 Methods for treatment of headaches by administration of oxytocin
12/20/2012US20120322735 Modified growth hormone polypeptides
12/20/2012US20120322734 Pharmaceutical Compositions Including Low Dosages of Desmopressin
12/20/2012US20120322733 Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
12/20/2012US20120322732 Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
12/20/2012US20120322731 Novel cytokine containing compositions
12/20/2012US20120322730 Methods and compositions for the prevention and treatment of anemia
12/20/2012US20120322729 High activity growth factor mutants
12/20/2012US20120322728 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases
12/20/2012US20120322727 Pharmaceutical Compositions for Intranasal Administration for the Treatment of Neurodegenerative Disorders
12/20/2012US20120322726 Therapeutic agent for eating disorders
12/20/2012US20120322725 Glucagon antagonist-gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
12/20/2012US20120322724 Molecules for targeting compounds to various selected organs or tissues
12/20/2012US20120322723 Use of interleukin-1 receptor antagonist for preparing medicament for preventing or treating epithelium trauma of intestinal mucosa
12/20/2012US20120322722 Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use
12/20/2012US20120322721 Dry growth hormone composition transiently linked to a polymer carrier
12/20/2012US20120322720 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
12/20/2012US20120322719 Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
12/20/2012US20120322718 Amygels in organic solvent for biomedical applications
12/20/2012US20120322717 Compounds and assays for controlling Wnt activity
12/20/2012US20120322689 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
12/20/2012US20120322674 Detecting cyp24 expression level as a marker for predisposition to cancer
12/20/2012US20120322663 Dry glassy composition comprising a bioactive material
12/20/2012US20120322105 Growth factor
12/20/2012US20120322100 Methods for producing modified glycoproteins
12/20/2012US20120321701 Ang-(1-7) receptor agonist
12/20/2012US20120321697 Bpb-based cargo delivery system
12/20/2012US20120321693 Prg4 treatment for interstitial cystitis
12/20/2012US20120321692 Methods and Dressings for Sealing Internal Injuries
12/20/2012US20120321687 Compositions and methods for using and identifying antimicrobial agents
12/20/2012US20120321685 Compositions containing oils having a specific gravity higher than the specific gravity of water
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321652 Peptides for active anti-cytokine immunization
12/20/2012US20120321639 Methods and compositions for the inhibition of stat5 in prostate cancer cells
12/20/2012US20120321635 Composition Containing Inhibitors of the Expression or Activity of SH3RF2 for Preventing or Treating Cancer
12/20/2012US20120321628 Hepatocyte growth factor receptor antagonists and uses thereof
12/20/2012US20120321625 Antibodies to ox-2/cd200 and uses thereof in inhibiting immune responses
12/20/2012US20120321624 Targeting the neuromuscular junction for treatment
12/20/2012US20120321623 ILT3 Polypeptides and Uses Thereof
12/20/2012US20120321612 Systems and methods for treating post-operative, acute, and chronic pain using an intra-muscular catheter administrated combination of a local anesthetic and a neurotoxin protein
12/20/2012US20120321611 Replenishment and Enrichment of Ocular Surface Lubrication
12/20/2012US20120321610 Method to inhibit neuropathic pain by intrathecal injection of protein phosphatases
12/20/2012US20120321609 Method of treating psychological disorders
12/20/2012US20120321608 Detection of mutations in a gene associated with resistance to viral infection, oas1
12/20/2012US20120321607 Factor VII Fusion Polypeptides
12/20/2012US20120321606 Crystal structures and methods using same
12/20/2012US20120321605 Artificial saliva comprising hyalulonic acid
12/20/2012US20120321604 Carrier comprising non-neutralised tocopheryl phosphate
12/20/2012US20120321603 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012US20120321599 Herpes virus strains
12/20/2012US20120321597 Methods and compositions for regenerating connective tissue
12/20/2012US20120321596 Kit for adhering biological hard tissues
12/20/2012US20120321594 Methods of controlling axon or dendrite development of neuronal cells
12/20/2012US20120321591 Anti-angiogenic compounds
12/20/2012US20120321590 Bridged polycyclic compounds
12/20/2012US20120321585 Crosslinked Hydrogels and Related Method of Preparation
12/20/2012US20120321575 Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis
12/20/2012US20120321556 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma
12/20/2012US20120321554 Plexin d1 as a target for tumor diagnosis and therapy
12/20/2012US20120321552 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
12/20/2012US20120318262 Pyrvinium Wound Treatment Methods and Devices
12/20/2012DE102011118029A1 Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung Modified antibiotic peptides with variable systemic release
12/20/2012CA2857705A1 Macrocyclic heterocyclic compounds for inhibiting hepatitis c virus and preparation and use thereof
12/20/2012CA2841416A1 Method of selecting therapeutic indications
12/20/2012CA2839538A1 High capacity diketopiperazine microparticles and methods
12/20/2012CA2839512A1 Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzyme
12/20/2012CA2839511A1 Stable formulations of a hyaluronan-degrading enzyme
12/20/2012CA2839408A1 Aromatic-cationic peptides and uses of same
12/20/2012CA2839298A1 Anti-inflammatory pharmaceutical products
12/20/2012CA2839296A1 Methods for increasing insulin sensitivity and treating diabetes
12/20/2012CA2838981A1 Group a streptococcus multivalent vaccine
12/20/2012CA2838662A1 Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
12/20/2012CA2838504A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/20/2012CA2838478A1 Soluble proteins for use as therapeutics
12/20/2012CA2838340A1 Method of treating or ameliorating metabolic disorders using clec-2
12/20/2012CA2836667A1 Freeze-dried formulations of fgf-18
12/20/2012CA2833676A1 A sustained-release composition containing peptides as active ingredient
12/19/2012EP2535406A1 Meganuclease variants cleaving a DNA target sequence from the human hemoglobin beta gene and uses thereof
12/19/2012EP2535348A1 Applications of the protein muns and the derivates thereof
12/19/2012EP2535347A1 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
12/19/2012EP2535346A1 Cellular libraries of peptide sequences (CLiPS) and methods of using the same
12/19/2012EP2535057A2 Compositions for the treatment of infectious and tumoural diseases
12/19/2012EP2535044A1 Enterically coated cysteamine, cystamine and derivatives thereof
12/19/2012EP2534171A1 Modified adam disintegrin domain polypeptides and uses thereof
12/19/2012EP2534170A1 Iap bir domain binding compounds
12/19/2012EP2534138A1 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors
12/19/2012EP2533815A1 Nucleic acid complexes
1 ... 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... 3163